These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7076747)

  • 1. Method for isolation and determination of pyridostigmine and metabolites in urine and blood.
    Ellin RI; Zvirblis P; Wilson MR
    J Chromatogr; 1982 Mar; 228():235-44. PubMed ID: 7076747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-performance liquid chromatographic determination of pyridostigmine bromide, nicotine, and their metabolites in rat plasma and urine.
    Abu-Qare AW; Abou-Donia MB
    J Chromatogr Sci; 2001 Jul; 39(7):287-92. PubMed ID: 11471991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversed-phase, ion-pair liquid chromatography of quaternary ammonium compounds: determination of pyridostigmine, neostigmine and edrophionium in biological fluids.
    De Ruyter MG; Cronnelly R
    J Chromatogr; 1980 Aug; 183(2):193-201. PubMed ID: 7400278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of pyridostigmine bromide, N,N-diethyl-m-toluamide, permethrin, and their metabolites in rat plasma and urine by high-performance liquid chromatography.
    Abu-Qare AW; Abou-Donia MB
    J Chromatogr B Biomed Sci Appl; 2000 Dec; 749(2):171-8. PubMed ID: 11145054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a high-performance liquid chromatographic method for the quantification of chlorpyrifos, pyridostigmine bromide, N,N-diethyl-m-toluamide and their metabolites in rat plasma and urine.
    Abu-Qare AW; Abou-Donia MB
    J Chromatogr B Biomed Sci Appl; 2001 Apr; 754(2):533-8. PubMed ID: 11339298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative gas-liquid chromatographic method for the determination of neostigmine and pyridostigmine in human plasma.
    Chan K; Williams NE; Baty JD; Calvey TN
    J Chromatogr; 1976 May; 120(2):349-58. PubMed ID: 1270556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatographic method for the determination of diazepam, pyridostigmine bromide, and their metabolites in rat plasma and urine.
    Abu-Qare AW; Abou-Donia MB
    J Chromatogr B Biomed Sci Appl; 2001 Apr; 754(2):503-9. PubMed ID: 11339294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A validated HPLC method for the determination of pyridostigmine bromide, acetaminophen, acetylsalicylic acid and caffeine in rat plasma and urine.
    Abu-Qare AW; Abou-Donia MB
    J Pharm Biomed Anal; 2001 Dec; 26(5-6):939-47. PubMed ID: 11600306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The simultaneous monitoring of plasma levels of neostigmine and pyridostigmine in man.
    Davison SC; Hyman N; Prentis RA; Dehghan A; Chan K
    Methods Find Exp Clin Pharmacol; 1980 Apr; 2(2):77-82. PubMed ID: 7339332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The excretion and metabolism of oral 14C-pyridostigmine in the rat.
    Husain MA; Roberts JB; Thomas BH; Wilson A
    Br J Pharmacol; 1968 Oct; 34(2):445-50. PubMed ID: 5687596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermospray mass spectrometer as a quantitative specific, sensitive, detector for liquid chromatography. Its application to the analysis of pyridostigmine in human plasma.
    Malcolm SL; Madigan MJ; Taylor NL
    J Pharm Biomed Anal; 1990; 8(8-12):771-6. PubMed ID: 2100621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of pyridostigmine plasma concentrations by high-performance liquid chromatography.
    Michaelis HC
    J Chromatogr; 1990 Dec; 534():291-4. PubMed ID: 2094721
    [No Abstract]   [Full Text] [Related]  

  • 13. Determination of depleted uranium, pyridostigmine bromide and its metabolite in plasma and urine following combined administration in rats.
    Abu-Qare AW; Abou-Donia MB
    J Pharm Biomed Anal; 2001 Sep; 26(2):281-9. PubMed ID: 11470205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A radioimmunoassay for pyridostigmine.
    Meyer HG; Lukey BJ; Gepp RT; Corpuz RP; Lieske CN
    J Pharmacol Exp Ther; 1988 Nov; 247(2):432-8. PubMed ID: 3183945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of pyridostigmine in plasma using high-performance liquid chromatography.
    Yakatan GJ; Tien JY
    J Chromatogr; 1979 Nov; 164(3):399-403. PubMed ID: 544615
    [No Abstract]   [Full Text] [Related]  

  • 16. Radioimmunoassay of pyridostigmine in plasma and tissues.
    Miller RL; Verma P
    Pharmacol Res; 1989; 21(4):359-68. PubMed ID: 2771855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolites of neostigmine and pyridostigmine do not contribute to antagonism of neuromuscular blockade in the dog.
    Hennis PJ; Cronnelly R; Sharma M; Fisher DM; Miller RD
    Anesthesiology; 1984 Nov; 61(5):534-9. PubMed ID: 6149707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatographic determination of pyridostigmine in plasma.
    Matsunaga H; Suehiro T; Saita T; Nakano Y; Mori M; Takata K; Oda K
    J Chromatogr; 1987 Nov; 422():353-5. PubMed ID: 3437025
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of chronic pyridostigmine administration on pyridostigmine-14C metabolism in myasthenia gravis.
    Kornfeld P; Wolf RL; Samuels AJ; Osserman KE
    Neurology; 1971 May; 21(5):550-2. PubMed ID: 5104099
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma clearance of neostigmine and pyridostigmine in the dog.
    Baker PR; Calvey TN; Chan K; Macnee CM; Taylor K
    Br J Pharmacol; 1978 Jul; 63(3):509-12. PubMed ID: 667495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.